Equity, Diversity, & Inclusion Committee

The main function of the Equity, Diversity and Inclusion (EDI) Committee is to monitor and report on the progress of the BioCanRx EDI Action Plan. The committee will act in an advisory capacity to the BioCanRx Board of Directors with respect to EDI matters. The EDI Committee includes two members of BioCanRx’s Board of Directors, and three members external to the Board who are experts in the area of equity, diversity and inclusion related to the science academic sector.


Members of the committee


Dr. Tina Gruosso (She/Her)
Scientist, Forbius
Gillian Carleton (They/Them)
PhD Student, University of Victoria
Aaron Prosper (He/Him)
Project Manager, Nova Scotia Mi’kmaw Nation Cancer Care Strategy
Graduate Student, University of Prince Edward Island
Dr. John Stagg (He/Him)
Associate Professor, Faculty of Pharmacy at the University of Montreal
Lab Head at the CHUM Hospital Research Centre
Debra Lynkowski
Chief Operating Officer
The Ottawa Hospital Research Institute


BioCanRx Staff


Dr. Stéphanie Michaud, President and Chief Executive Officer Dr. Megan Mahoney, Director, Scientific Affairs and Training Programs Ms. Laurie Cameron, Manager, Knowledge Mobilization & Corporate Operations




Sara Esam, Senior Program Manager, College and Networks, Networks of Centres of Excellence (NCE)